(Q36379589)

13 August 2017

1 reference

title

Mechanisms of dyslipidemia of chronic renal failure (English)

1 reference

13 August 2017

1 reference

Nosratola D Vaziri

1

1 reference

13 August 2017

Hamid Moradi

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Hemodialysis International

13 August 2017

published in

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

1-7

1 reference

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Inflammation in end-stage renal disease: sources, consequences, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Lipoprotein metabolism and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Dialysis modalities and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Cellular cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Tangier disease and ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Molecular mechanisms of lipid disorders in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.01168.X

10.1111/J.1542-4758.2006.01168.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference